Cancer Clinical Trials

Medical oncologist Peter O'Donnell, MD, meets with a patient

Participate In a Cancer Clinical Trial

Clinical trials are research studies involving people. Some trials test the safety and effectiveness of new cancer treatments. Others may test new procedures or approaches for cancer screening or prevention. Clinical trials follow very detailed and strict procedures for administering the new treatment or procedure and measuring its effects (both good and bad) on patients, compared to the standard approach. Clinical trials help improve existing treatment options for patients.

All improvements in cancer care were made possible because of clinical trials.

Frequently Asked Questions
Search for a Clinical Trial

Find a Cancer Clinical Trial

Clinical trials are an important step in making advances in cancer treatment. Our dedicated researchers and clinicians conduct hundreds of clinical trials in phases I, II, III and IV each year, leading to the development of new and better treatments. If you are a patient or a caregiver and would like to learn more about cancer clinical trials at the University of Chicago Medicine, call 1-855-702-8222 (adult trials) or 1-773-702-2927 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu.

Cancer Clinical Trials at UChicago Medicine Ingalls Memorial

UChicago Medicine Ingalls Memorial Hospital in Harvey, Ill. is conducting clinical trials of new treatments for a wide variety of cancers, from breast cancer and lung cancer, to multiple myeloma and pancreatic cancer.

Convenient Locations for Cancer Care

Video placeholder
What Does It Mean to Be an NCI-Designated Comprehensive Cancer Center?

An official comprehensive cancer center designation by the National Cancer Institute (NCI) is the highest federal rating a cancer center can achieve. Learn what's required to earn this designation and how the UChicago Medicine Comprehensive Cancer Center is shaping cancer care and research today and beyond.

Watch Video

Cancer Articles

Cristian Carpio is a long-time participant in UChicago Medicine Comprehensive Cancer Center
Summer research programs: Creating life-changing experiences for high school and undergraduate students
Researchers have long suspected that interleukin-12 could be a powerful cancer treatment, but it caused dangerous side effects. Now, Pritzker Molecular Engineering researchers have developed a version of the molecule that activates when it reaches a tumor, whereupon it eradicates cancer cells.
‘Masked’ cancer drug sneaks through body to deliver anti-tumor treatment with fewer side effects
Pictured (left to right): Nan Chen, MD; Xiaoyang Wu, PhD; Scott Oakes, MD; Ray Moellering, PhD; Marsha Rosner, PhD; Margarite Matossian, MD, PhD; Rita Nanda, MD.
Ullman Family Team Science Award to support novel breast cancer research
A 3D illustration of multiple myeloma, a type of cancer.
Study shows promising results for triple-drug therapy for post-transplant management of multiple myeloma
Father watching as doctor places bandage on teen
Protecting teens and preteens from HPV-related cancers: What parents need to know about the vaccine, risk and more
A medical professional discusses options with a patient who is wearing a head scarf.
UChicago Medicine receives American Cancer Society grant for oncology patient navigation program
Laura Furmanek
Encouraging new drug helps Northwest Indiana woman with relapsed ovarian cancer
A woman sitting on an exam table consults with a doctor.
Black women more likely to die from breast cancer: What factors are influencing this disparity and how can they be addressed?
Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immunotherapy and leukemia or lymphoma symbol and medical therapy as a 3D render.
ASH meeting brings blood cancer experts together in person for the first time since the pandemic